Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success

Reproduction

Volumn 150, Issue 6, 2015, Pages R175-R184

  Casarini, Livio ^a   Santi, Daniele ^a,b   Marino, Marco ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b AUSL Modena   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; GONADOTROPIN RECEPTOR;

FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SELECTION; GENETICS; HUMAN; INFERTILITY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; PROGNOSIS; REPRODUCTION; RISK FACTOR; SEX DIFFERENCE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADOTROPINS; HUMANS; INFERTILITY; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; PREGNANCY; PROGNOSIS; RECEPTORS, GONADOTROPIN; REPRODUCTION; RISK FACTORS; SELECTION, GENETIC; SEX FACTORS;

EID: 84957811723     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-15-0251     Document Type: Review

References (77)

1. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV & Mahale SD 2009 Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reproductive Biomedicine Online 18 509-515. (doi:10.1016/S1472-6483 (10) 60127-7)
2. Apicella CL, Marlowe FW, Fowler JH & Christakis NA 2012 Social networks and cooperation in hunter-gatherers. Nature 481 497-501. (doi:10.1038/nature10736)
3. Ascoli M, Fanelli F & Segaloff DL 2002 The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocrine Reviews 23 141-174. (doi:10.1210/edrv. 23.2.0462)
4. Assis R & Bachtrog D 2013 Neofunctionalization of young duplicate genes in Drosophila. PNAS 110 17409-17414. (doi:10.1073/pnas. 1313759110)
5. Binder H, Strick R, Zaherdoust O, Dittrich R, Hamori M, BeckmannMW & Oppelt PG 2012 Assessment of FSHR variants and antiMüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertility and Sterility 97 1169-1175.e1. (doi:10.1016/j.fertnstert.2012.02.012)
6. Bongaarts J 2015 Global fertility and population trends. Seminars in Reproductive Medicine 33 5-10. (doi:10.1055/s-0034-1395272)
7. Cann HM, de Toma C, Cazes L, Legrand MF, Morel V, Piouffre L, Bodmer J, Bodmer WF, Bonne-Tamir B, Cambon-Thomsen A et al. 2002 A human genome diversity cell line panel. Science 296 261-262. (doi:10.1126/science.296.5566.261b)
8. Casarini L & Brigante G 2014 The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. Journal of Clinical Endocrinology and Metabolism 99 E2412-E2420. (doi:10.1210/jc.2014-2703)
9. Casarini L, Pignatti E & Simoni M 2011 Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Reviews in Endocrine & Metabolic Disorders 12 303-321. (doi:10.1007/s11154-011-9192-2)
10. Casarini L, Moriondo V, Marino M, Adversi F, Capodanno F, Grisolia C, La Marca A, La Sala GB & Simoni M 2014 FSHR polymorphism p. N680S mediates different responses to FSH in vitro. Molecular and Cellular Endocrinology 393 83-91. (doi:10.1016/j.mce.2014.06.013)
11. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J et al. 2011 Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nature Genetics 43 55-59. (doi:10.1038/ng.732)
12. Christensen K, Doblhammer G, Rau R & Vaupel JW 2009 Ageing populations: the challenges ahead. Lancet 374 1196-1208. (doi:10.1016/S0140-6736 (09) 61460-4)
13. Cole LA 2009 hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation. Journal of Reproductive Immunology 82 112-118. (doi:10.1016/j.jri.2009.04.007)
14. Corbett S & Morin-Papunen L 2013 The polycystic ovary syndrome and recent human evolution. Molecular and Cellular Endocrinology 373 39-50. (doi:10.1016/j.mce.2013.01.001)
15. Cornelius JM, Watts HE, Dingle H & Hahn TP 2013 Obligate versus rich patch opportunism: evolution and endocrine mechanisms. General and Comparative Endocrinology 1 76-80. (doi:10.1016/j.ygcen. 2013.04.003)
16. Elkins DA, Yokomizo A, Thibodeau SN, J Schaid D, Cunningham JM, Marks A, Christensen E, McDonnell SK, Slager S, J Peterson B et al. 2003 Luteinizing hormone b polymorphism and risk of familial and sporadic prostate cancer. Prostate 56 30-36. (doi:10.1002/pros.10220)
17. Gilks WP, Abbott JK & Morrow EH 2014 Sex differences in disease genetics: evidence, evolution, and detection. Trends in Genetics 30 453-463. (doi:10.1016/j.tig.2014.08.006)
18. Gloaguen P, Crépieux P, Heitzler D, Poupon A & Reiter E 2011 Mapping the follicle-stimulating hormone-induced signaling networks. Frontiers in Endocrinology 2 45. (doi:10.3389/fendo.2011.00045)
19. Grigorova M, Rull K & Laan M 2007 Haplotype structure of FSHB, the b-subunit gene for fertility-associated follicle-stimulating hormone: possible influence of balancing selection. Annals of Human Genetics 71 18-28. (doi:10.1111/j.1469-1809.2006.00299.x)
20. Grigorova M, Punab M, Ausmees K & Laan M 2008 FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Human Reproduction 23 2160-2166. (doi:10.1093/humrep/den216)
21. Grigorova M, Punab M, Punab AM, Poolamets O, Vihljajev V, Zilaitienę B, Erenpreiss J, Matulevičius V & Laan M 2014 Reproductive physiology in young men is cumulatively affected by FSH-action modulating genetic variants: FSHR K29G/A and c.2039 A/G, FSHB K211G/T. PLoS ONE 9 e94244. (doi:10.1371/journal.pone.0094244)
22. Forsman A 2014 Effects of genotypic and phenotypic variation on establishment are important for conservation, invasion, and infection biology. PNAS 111 302-307. (doi:10.1073/pnas.1317745111)
23. Gettler LT, McDade TW, Agustin SS, Feranil AB & Kuzawa CW 2013 Do testosterone declines during the transition to marriage and fatherhood relate to men's sexual behavior? Evidence from the Philippines Hormones and Behavior 64 755-763. (doi:10.1016/j.yhbeh.2013.08.019)
24. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L & Simoni M 2005 A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 90 4866-4872. (doi:10.1210/jc.2004-2268)
25. Haasl RJ, Ahmadi MR, Meethal SV, Gleason CE, Johnson SC, Asthana S, Bowen RL & Atwood CS 2008 A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele. BMC Medical Genetics 9 37. (doi:10.1186/1471-2350-9-37)
26. Hallast P, Rull K & Laan M 2007 The evolution and genomic landscape of CGB1 and CGB2 genes. Molecular and Cellular Endocrinology 260-262 2-11. (doi:10.1016/j.mce.2005.11.049)
27. Henke A & Gromoll J 2008 New insights into the evolution of chorionic gonadotrophin. Molecular and Cellular Endocrinology 291 11-19. (doi:10.1016/j.mce.2008.05.009)
28. Heyer E, Brandenburg JT, Leonardi M, Toupance B, Balaresque P, Hegay T, Aldashev A & Austerlitz F 2015 Patrilineal populations show more male transmission of reproductive success than cognatic populations in Central Asia, which reduces their genetic diversity. American Journal of Physical Anthropology 157 537-543. (doi:10.1002/ajpa.22739)
29. International HapMap Consortium 2003 The International HapMap Project. Nature 426 789-796. (doi:10.1038/nature02168)
30. Jia J, Wei YL, Qin CJ, Hu L, Wan LH & Li CX 2014 Developing a novel panel of genome-wide ancestry informative markers for bio-geographical ancestry estimates. Forensic Science International. Genetics 8 187-194. (doi:10.1016/j.fsigen. 2013.09.004)
31. Jiang M, Pakarinen P, Zhang FP, El-Hefnawy T, Koskimies P, Pettersson K & Huhtaniemi I 1999 A common polymorphic allele of the human luteinizing hormone b-subunit gene: additional mutations and differential function of the promoter sequence. Human Molecular Genetics 8 2037-2046. (doi:10.1093/hmg/8.11.2037)
32. Kaleva M, Virtanen H, Haavisto AM, Main K, Skakkebaek NE, Huhtaniemi I, Irjala K & Toppari J 2005 Does variant luteinizing hormone (V-LH) predispose to improper testicular position in late pregnancy? Pediatric Research 58 447-450. (doi:10.1203/01.pdr. 0000176918.68539.b4)
33. Kuningas M, Altmäe S, Uitterlinden AG, Hofman A, van Duijn CM & Tiemeier H 2011 The relationship between fertility and lifespan in humans. Age 33 615-622. (doi:10.1007/s11357-010-9202-4)
34. La Marca A, Papaleo E, Alviggi C, Ruvolo G, De Placido G, Candiani M, Cittadini E, De Michele F, Moriondo V, Catellani V et al. 2013 The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductiveage. Human Reproduction 28 1369-1374. (doi:10.1093/humrep/det061)
35. Li JZ, Absher DM, Tang H, Southwick AM, Casto AM, Ramachandran S, Cann HM, Barsh GS, Feldman M, Cavalli-Sforza LL et al. 2008 Worldwide human relationships inferred from genome-wide patterns of variation. Science 319 1100-1104. (doi:10.1126/science.1153717)
36. Liu X, Ong RT, Pillai EN, Elzein AM, Small KS, Clark TG, Kwiatkowski DP & Teo YY 2013 Detecting and characterizing genomic signatures of positive selection in global populations. American Journal of Human Genetics 92 866-881. (doi:10.1016/j.ajhg.2013.04.021)
37. Lledo B, Guerrero J, Turienzo A, Ortiz JA, Morales R, Ten J, Llacer J & Bernabeu R 2013 Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenetics and Genomics 23 262-268. (doi:10.1097/FPC.0b013e32835fe813)
38. Ludwig AH, Murawska M, Panek G, Timorek A & Kupryjanczyk J 2009 Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome. Endocrine-Related Cancer 16 1005-1016. (doi:10.1677/ERC-08-0135)
39. Meier-Abt F, Bentires-Alj M & Rochlitz C 2015 Breast cancer prevention: lessons to be learned from mechanisms of early pregnancy-mediated breast cancer protection. Cancer Research 75 803-807. (doi:10.1158/0008-5472. CAN-14-2717)
40. Mertens-Walker I, Baxter RC & Marsh DJ 2012 Gonadotropin signalling in epithelial ovarian cancer. Cancer Letters 324 152-159. (doi:10.1016/j. canlet.2012.05.017)
41. Mills SC, Koskela E & Mappes T 2012 Intralocus sexual conflict for fitness: sexually antagonistic alleles for testosterone. Proceedings. Biological Sciences/The Royal Society 279 1889-1895. (doi:10.1098/rspb.2011.2340)
42. Mohiyiddeen L, Newman WG, Cerra C, McBurney H, Mulugeta B, Roberts SA & Nardo LG 2013 A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertility and Sterility 99 149-155. (doi:10.1016/j.fertnstert.2012.08.037)
43. Nagirnaja L, Rull K, Uusküla L, Hallast P, Grigorova M & Laan M 2010 Genomics and genetics of gonadotropin b-subunit genes: unique FSHB and duplicated LHB/CGB loci. Molecular and Cellular Endocrinology 329 4-16. (doi:10.1016/j.mce.2010.04.024)
44. Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, Makita Y, Hata A, Yamada M, Takahashi N et al. 2006 Mutation of the folliclestimulating hormone receptor gene 50-untranslated region associated with female hypertension. Hypertension 48 512-518. (doi:10.1161/01. HYP.0000233877.84343.d7)
45. O'Brien TJ, Kalmin MM, Harralson AF, Clark AM, Gindoff I, Simmens SJ, Frankfurter D & Gindoff P 2013 Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reproductive Biology and Endocrinology 11 71. (doi:10.1186/1477-7827-11-71)
46. Parrott AM, Sriram G, Liu Y & Mathews MB 2011 Expression of type II chorionic gonadotropin genes supports a role in the male reproductive system. Molecular and Cellular Biology 31 287-299. (doi:10.1128/MCB. 00603-10)
47. Pennell TM & Morrow EH 2013 Two sexes, one genome: the evolutionary dynamics of intralocus sexual conflict. Ecology and Evolution 3 1819-1834. (doi:10.1002/ece3.540)
48. Perini T, Ditzen B, Hengartner M & Ehlert U 2012 Sensation seeking in fathers: the impact on testosterone and paternal investment. Hormones and Behavior 61 191-195. (doi:10.1016/j.yhbeh.2011.12.004)
49. Perry JR, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, He C, Chasman DI, Esko T, Thorleifsson G et al. 2014 Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature 514 92-97. (doi:10.1038/nature13545)
50. Pettersson K, Ding YQ & Huhtaniemi I 1992 An immunologically anomalous luteinizing hormone variant in a healthy woman. Journal of Clinical Endocrinology & Metabolism 74 164-171. (doi:10.1210/jcem. 74.1.1727817)
51. Piersma D, Berns EM, Verhoef-Post M, Uitterlinden AG, Braakman I, Pols HA & Themmen AP 2006 A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. Journal of Clinical Endocrinology and Metabolism 91 1470-1476. (doi:10.1210/jc.2005-2156)
52. Pollet TV, Cobey KD & van der Meij L 2013 Testosterone levels are negatively associated with fatherhood (corrected) in males, but positively related to offspring count in fathers. PLoS ONE 8 e60018. (doi:10.1371/journal.pone.0060018)
53. Powell BL, Piersma D, Kevenaar ME, van Staveren IL, Themmen AP, Iacopetta BJ & Berns EM 2003 Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset. Journal of Clinical Endocrinology and Metabolism 88 1653-1657. (doi:10.1210/jc.2002-021585)
54. Ramachandran S, Deshpande O, Roseman CC, Rosenberg NA, Feldman MW & Cavalli-Sforza LL 2005 Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. PNAS 102 15942-15947. (doi:10. 1073/pnas.0507611102)
55. Rull K, Nagirnaja L, Ulander VM, Kelgo P, Margus T, Kaare M, Aittomäki K & Laan M 2008 Chorionic gonadotropin b-gene variants are associated with recurrent miscarriage in two European populations. Journal of Clinical Endocrinology and Metabolism 93 4697-4706. (doi:10.1210/jc. 2008-1101)
56. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, Xie X, Byrne EH, McCarroll SA, Gaudet R et al. 2007 Genome-wide detection and characterization of positive selection in human populations. Nature 449 913-918. (doi:10.1038/nature06250)
57. Saltzman W & Ziegler TE 2014 Functional significance of hormonal changes in mammalian fathers. Journal of Neuroendocrinology 26 685-696. (doi:10.1111/jne.12176)
58. Schonfeld SJ, Neta G, Sturgis EM, Pfeiffer RM, Hutchinson AA, Xu L, Wheeler W, Guénel P, Rajaraman P, de Vathaire F et al. 2012 Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid 22 151-156. (doi:10.1089/thy.2011.0309)
59. Schüring AN, Busch AS, Bogdanova N, Gromoll J & Tüttelmann F 2013 Effects of the FSH-b-subunit promoter polymorphism K211G/T on the hypothalamic-pituitary-ovarian axis innormally cycling women indicate a gender-specific regulation of gonadotropin secretion. Journal of Clinical Endocrinology and Metabolism 98 E82-E86. (doi:10.1210/jc. 2012-2780)
60. Sharma R, Biedenharn KR, Fedor JM & Agarwal A 2013 Lifestyle factors and reproductive health: taking control of your fertility. Reproductive Biology and Endocrinology 11 66. (doi:10.1186/1477-7827-11-66)
61. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J et al. 2012 Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nature Genetics 44 1020-1025. (doi:10.1038/ng.2384)
62. Simoni M & Casarini L 2014 Mechanisms in endocrinology: Genetics of FSH action: a 2014-and-beyond view. European Journal of Endocrinology 170 R91-R107. (doi:10.1530/EJE-13-0624)
63. Simoni M, Gromoll J & Nieschlag E 1997 The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Reviews 18 739-773. (doi:10.1210/edrv. 18.6.0320)
64. Simoni M, Tüttelmann F, Michel C, Böckenfeld Y, Nieschlag E & Gromoll J 2008 Polymorphisms of the luteinizing hormone/chorionic gonadotropin receptor gene: association with maldescended testes and male infertility. Pharmacogenetics and Genomics 18 193-200. (doi:10.1097/FPC. 0b013e3282f4e98c)
65. Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, Barbalic M, Broer L, Byrne EM, Ernst F et al. 2012 Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nature Genetics 44 260-268. (doi:10.1038/ng.1051)
66. Sun Y & Ji X 2014 Association of rs7260002 of chorionic gonadotrophin b5 with idiopathic recurrent spontaneous abortion in Chinese population. Journal of Assisted Reproduction and Genetics 31 1497-1500. (doi:10. 1007/s10815-014-0321-1)
67. Sun J, Song F, Wang J, Han G, Bai Z, Xie B, Feng X, Jia J, Duan Y & Lei H 2014 Hidden risk genes with high-order intragenic epistasis in Alzheimer's disease. Journal of Alzheimer's Disease 41 1039-1056. (doi:10.3233/JAD-140054)
68. Takezaki N, Nei M & Tamura K 2010 POPTREE2: software for constructing population trees from allele frequency data and computing other population statistics with Windows interface. Molecular Biology and Evolution 27 747-752. (doi:10.1093/molbev/msp312)
69. Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS et al. 1999 A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. Journal of Clinical Endocrinology & Metabolism 84 1711-1715. (doi:10.1210/jcem.84.5.5702)
70. Thathapudi S, Kodati V, Erukkambattu J, Addepally U & Qurratulain H 2015 Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genetic Testing and Molecular Biomarkers 19 128-132. (doi:10.1089/gtmb.2014.0249)
71. Tehrani FR, Solaymani-Dodaran M, Hedayati M & Azizi F 2010 Is polycystic ovary syndrome an exception for reproductive aging? Human Reproduction 25 1775-1781. (doi:10.1093/humrep/deq088)
72. Trevisan CM, Peluso C, Cordts EB, de Oliveira R, Christofolini DM, Barbosa CP & Bianco B 2014 Ala307Thr and Asn680Ser polymorphisms of FSHR gene in human reproduction outcomes. Cellular Physiology and Biochemistry 34 1527-1535. (doi:10.1159/000366356)
73. Tüttelmann F, Laan M, Grigorova M, Punab M, Sõber S & Gromoll J 2012 Combined effects of the variants FSHBK211GOT and FSHR 2039AOG on male reproductive parameters. Journal of Clinical Endocrinology and Metabolism 97 3639-3647. (doi:10.1210/jc.2012-1761)
74. Uusküla L, Rull K, Nagirnaja L & Laan M 2011 Methylation allelic polymorphism (MAP) in chorionic gonadotropin b5 (CGB5) and its association with pregnancy success. Journal of Clinical Endocrinology & Metabolism 96 E199-E207.
75. Vitzthum VJ 2009 The ecology and evolutionary endocrinology of reproduction in the human female. American Journal of Physical Anthropology 140 95-136. (doi:10.1002/ajpa.21195)
76. Vitzthum VJ, Spielvogel H & Thornburg J 2004 Interpopulational differences in progesterone levels during conception and implantation in humans. PNAS 101 1443-1448. (doi:10.1073/pnas.0302640101)
77. Yang CQ, Chan KY, Ngan HY, Khoo US, Chiu PM, Chan QK, Xue WC & Cheung AN 2006 Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 27 1502-1506. (doi:10.1093/carcin/bgl014)